The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
Open accessAbstract
Mice deficient in programmed cell death 1 (PD-1,Pdcd1), an immunoinhibitory receptor belonging to the CD28/cytotoxic T lymphocyte-associated antigen-4 family, spontaneously develop lupus-like autoimmune disease and autoimmune dilated cardiomyopathy on C57BL/6 and BALB/c backgrounds, respectively. However, how PD-1 deficiency induces different forms of autoimmune diseases on these two strains was unknown. Here, we report that PD-1 deficiency specifically accelerates the onset and frequency of type I diabetes in NOD (nonobese diabetic) mice, with strong T helper 1 polarization of T cells infiltrating into islets. These results suggest that PD-1 deficiency accelerates autoimmune predisposition of the background strain, leading to the induction of different forms of autoimmune diseases depending on the genetic background of the strain. Using NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes, we screened diabetes-susceptible loci by genetic linkage analysis. The diabetic incidence of NOD-Pdcd1-/-mice was controlled by five genetic loci, including three known recessive loci [Idd(insulin-dependent diabetes)1,Idd17, and Idd20] and two previously unidentified dominant loci [Iddp(Idd under PD-1 deficiency)1 and Iddp2].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results
Lander, E., & Kruglyak, L. (1995) · Nature Genetics · doi:10.1038/ng1195-241 · Cited by 5,239
Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,203
Self-citationNishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Self-citationSalomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,081
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Self-citationCarreno, B. M., & Collins, M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091101.091806 · Cited by 896
Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., & Honjo, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231486598 · Cited by 848
Self-citationThe Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
Ansari, M. J. I., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022125 · Cited by 814
Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., et al. (2003) · Nature Medicine · doi:10.1038/nm955 · Cited by 689
Self-citationThe Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
Delovitch, T. L., & Singh, B. (1997) · Immunity · doi:10.1016/s1074-7613(00)80392-1 · Cited by 676
Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J., & Sharpe, A. H. (2003) · European Journal of Immunology · doi:10.1002/eji.200324228 · Cited by 639
Latchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., Kuchroo, V. K., Freeman, G. J., & Sharpe, A. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307252101 · Cited by 636
Nishimura, H. (1998) · International Immunology · doi:10.1093/intimm/10.10.1563 · Cited by 500
Genetic analysis of autoimmune type 1 diabetes mellitus in mice
Todd, J. A., Aitman, T. J., Cornall, R. J., Ghosh, S., Hall, J. R. S., Hearne, C. M., Knight, A. M., Love, J. M., McAleer, M. A., Prins, J.-B., et al. (1991) · Nature · doi:10.1038/351542a0 · Cited by 493
Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cells
Tanigaki, K., Han, H., Yamamoto, N., Tashiro, K., Ikegawa, M., Kuroda, K., Suzuki, A., Nakano, T., & Honjo, T. (2002) · Nature Immunology · doi:10.1038/ni793 · Cited by 478
Self-citationPD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver
Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T., & Honjo, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022235 · Cited by 392
Self-citationA search for type 1 diabetes susceptibility genes in families from the United Kingdom
Mein, C., Esposito, L., Dunn, M. G., Johnson, G. C. L., Timms, A. E., Goy, J. V., Smith, A. N., Sebag-Montefiore, L., Merriman, M. E., Wilson, A. J., et al. (1998) · Nature Genetics · doi:10.1038/991 · Cited by 323
Dynamics of Pathogenic and Suppressor T Cells in Autoimmune Diabetes Development
Gregori, S., Giarratana, N., Smiroldo, S., & Adorini, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4040 · Cited by 236
New regulatory co-receptors: inducible co-stimulator and PD-1
Okazaki, T., Iwai, Y., & Honjo, T. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00398-9 · Cited by 226
Self-citationGreen, E. A., Eynon, E. E., & Flavell, R. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80670-6 · Cited by 197
Nishimura, H., Honjo, T., & Minato, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.891 · Cited by 192
Self-citationLocal expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection
Subudhi, S. K., Zhou, P., Yerian, L. M., Chin, R. K., Lo, J. C., Anders, R. A., Sun, Y., Chen, L., Wang, Y., Alegre, M.-L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19210 · Cited by 161
Shim, G.-J., Warner, M. N., Kim, H., Andersson, S., Liu, L., Ekman, J., Imamov, O., Jones, M. E. E., Simpson, E. R., & Gustafsson, J.-Α. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405099101 · Cited by 160
Butterfield, R. J., Sudweeks, J. D., Blankenhorn, E. P., Korngold, R., Marini, J. C., Todd, J. A., Roper, R. J., & Teuscher, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1860 · Cited by 152
Genetic dissection of systemic lupus erythematosus
Wakeland, E. K., Wandstrat, A. E., Liu, K., & Morel, L. M. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00039-4 · Cited by 151
Crosses of NOD Mice With the Related NON Strain: A Polygenic Model for IDDM
McAleer, M. A., Reifsnyder, P. C., Palmer, S. M., Procházka, M., Love, J. M., Copeman, J. B., Powell, E. E., Rodrigues, N. R., Prins, J., SERREZE, D. V., et al. (1995) · Diabetes · doi:10.2337/diab.44.10.1186 · Cited by 140
Verdaguer, J., Yoon, J., Anderson, B., Averill, N., Utsugi, T., Park, B. J., & Santamaría, P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4726 · Cited by 129
Understanding autoimmune diabetes: insights from mouse models
Adorini, L., Gregori, S., & Harrison, L. C. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02193-1 · Cited by 116
van Blokland, S. C. A., & Versnel, M. A. (2002) · Clinical Immunology · doi:10.1006/clim.2002.5189 · Cited by 107
Griffiths, M. M., Encinas, J. A., Remmers, E. F., Kuchroo, V. K., & Wilder, R. L. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00038-2 · Cited by 80
Susceptibility genes in the pathogenesis of murine lupus.
Nguyen, C., Limaye, N., & Wakeland, E. K. (2002) · Arthritis Research · doi:10.1186/ar583 · Cited by 55
Peritoneal B cells govern the outcome of diabetes in non‐obese diabetic mice
Kendall, P. L., Woodward, E. J., Hulbert, C., & Thomas, J. W. (2004) · European Journal of Immunology · doi:10.1002/eji.200324744 · Cited by 52
Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice
Yang, Y., & Santamaría, P. (2003) · Diabetologia · doi:10.1007/s00125-003-1218-1 · Cited by 37
Cited by
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
Regulation and Function of the PD-L1 Checkpoint
Sun, C., Mezzadra, R., & Schumacher, T. N. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.014 · Cited by 2,193
The diverse functions of the PD1 inhibitory pathway
Sharpe, A. H., & Pauken, K. E. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.108 · Cited by 1,971
Metadata
- Authors
- Wang, J., Yoshida, T., Nakaki, F., Hiai, H., Okazaki, T., & Honjo, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-08-08
- Volume
- 102
- Issue
- 33
- Pages
- 11823-11828
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2085604821
- Cited by
- 437
- References
- 35
- FWCI
- 8.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.